Showing results (71-80 of 278) with videos related to
Sort By:
Pageof 28
Pharmaceutical Patent Analyst|November 16, 2022
Co-processed tablet excipient composition, its preparation and use: US10071059 B2: patent spotlightSajal Jain, Ritu Rathi, Upendra Nagaich, et al.Pharmaceutical Patent Analyst|April 19, 2016
Mangiferin: a promising anticancer bioactiveRajneet K Khurana, Ranjot Kaur, Shikha Lohan, et al.Pharmaceutical Patent Analyst|July 8, 2014
Targeting the inhibitor of Apoptosis Protein BIR3 binding domainsJames B JaquithPharmaceutical Patent Analyst|April 19, 2016
Humira: the impending patent battles over adalimumab biosimilarsPeter NormanPharmaceutical Patent Analyst|December 22, 2020
Recent patents in dengue disease managementSukhbir K ShahidPharmaceutical Patent Analyst|June 2, 2021
Treating of focal epilepsy: a patent reviewSlobodan M Janković, Nenad Marković, Tanja LukovićPharmaceutical Patent Analyst|September 10, 2016
Fluorine-18 patents (2009-2015). Part 2: new radiochemistryAndrew V Mossine, Stephen Thompson, Allen F Brooks, et al.Pharmaceutical Patent Analyst|February 17, 2022
Multicomponent crystal compromising dasatinib and selected co-crystals formers: a patent evaluation of EP2861589B1Ritu Rathi, Inderbir SinghPharmaceutical Patent Analyst|July 21, 2022
Six drugs facing key patent expirations and potential generic entry from May to June 2022Yali FriedmanPageof 28